Aura Biosciences

Pioneering A New Approach To Cancer Drug Delivery

Aura Biosciences has cobbled together a new approach to delivering cancer drugs by combining unrelated discoveries from European research institutions in the fields of virology, molecular biology, advanced chemistry, and nanotechnology. The company, which is headed by Spanish molecular biologist Elisabet de los Pinos, is one of 26 companies named as 2010 Technology Pioneers by the World Economic Forum.Read more

Syndicate content